The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer

被引:61
作者
Eisenkop, SM
Spirtos, NM
机构
[1] Encino Tarzana, Womens Canc Ctr, Tarzana, CA 91356 USA
[2] Womens Canc Ctr, Palo Alto, CA 94304 USA
关键词
D O I
10.1006/gyno.2001.6232
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective, The goal of this study was to determine the time during primary cytoreduction when retroperitoneal lymph nodes that are involved with macroscopic disease are recognized to be involved with tumor, the dimensions of intranodal disease present, and the possible clinical significance of macroscopically positive nodes that are recognized at different phases of the operation, Methods. One hundred consecutive patients with stage IIIC and TV epithelial ovarian cancer underwent a retroperitoneal lymph node dissection during primary cytoreductive surgery. The phase of the operation in which nodes were recognized to be macroscopically involved with tumor was noted, Nodes were classified to be positive by palpation if recognized to be macroscopically involved by transperitoneal palpation, positive by inspection if recognized to be macroscopically involved by palpation after opening the retroperitoneal area, and positive by dissection if recognized to be macroscopically involved anytime after starting the actual process of lymph node dissection. The largest dimension of the intranodal disease in macroscopically positive nodes was measured. Log rank analysis determined whether nodal status or the time at which the nodes were recognized to be macroscopically positive influenced the probability of survival, Results. Of the 100 patients, 66 had positive lymph nodes. Five were microscopically positive and 61 were macroscopically positive, of which 19 (31.1%) were positive by palpation, 16 (26.2%) were positive by inspection, 26 (42.6%) were positive by dissection. Of the 39 patients with negative and microscopically positive nodes 15 (38.5%) were clinically suspicious. Compared with patients with negative and microscopically positive lymph nodes, survival was not significantly different for patients who required excision of macroscopically positive nodal tissue. Survival was not influenced by the specific phase of surgery in which macroscopically positive nodes were recognized. Conclusions. A significant percentage of patients had retroperitoneal nodes recognized to be involved with macroscopic disease only after a lymph node dissection was in progress. The decision not to perform a lymph node dissection for optimally and completely cytoreduced patients may result in unrecognized macroscopic residual disease that is larger than what would otherwise be documented. (C) 2001 Academic Press.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 30 条
[1]   Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer [J].
Alberts, DS ;
Liu, PY ;
Hannigan, EV ;
OToole, R ;
Williams, SD ;
Young, JA ;
Franklin, EW ;
ClarkePearson, DL ;
Malviya, VK ;
DuBeshter, B ;
Adelson, MD ;
Hoskins, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1950-1955
[2]  
Allen DG, 1999, AUST NZ J OBSTET GYN, V39, P420
[3]   Accuracy of lymph node palpation to determine need for lymphadenectomy in gynecologic malignancies [J].
Arango, HA ;
Hoffman, MS ;
Roberts, WS ;
Decesare, SL ;
Fiorica, JV ;
Drake, J .
OBSTETRICS AND GYNECOLOGY, 2000, 95 (04) :553-556
[4]   ELECTROSURGICAL DEBULKING OF OVARIAN-CANCER - A NEW TECHNIQUE USING THE ARGON BEAM COAGULATOR [J].
BRAND, E ;
PEARLMAN, N .
GYNECOLOGIC ONCOLOGY, 1990, 39 (02) :115-118
[5]   PELVIC LYMPHADENECTOMY IN OPERATIVE TREATMENT OF OVARIAN-CANCER [J].
BURGHARDT, E ;
PICKEL, H ;
LAHOUSEN, M ;
STETTNER, H .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 155 (02) :315-319
[6]  
CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO
[7]  
2-8
[8]   PELVIC AND PARA-AORTIC LYMPHADENECTOMY IN CANCER OF THE OVARY [J].
DIRE, F ;
FONTANELLI, R ;
RASPAGLIESI, F ;
DIRE, E .
BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY, 1989, 3 (01) :131-142
[9]   Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: Prognostic significance of node metastases [J].
diRe, F ;
Baiocchi, G ;
Fontanelli, R ;
Grosso, G ;
Cobellis, L ;
Raspagliesi, F ;
diRe, E .
GYNECOLOGIC ONCOLOGY, 1996, 62 (03) :360-365
[10]   PERITONEAL IMPLANT ELIMINATION DURING CYTOREDUCTIVE SURGERY FOR OVARIAN-CANCER - IMPACT ON SURVIVAL [J].
EISENKOP, SM ;
NALICK, RH ;
WANG, HJ ;
TENG, NNH .
GYNECOLOGIC ONCOLOGY, 1993, 51 (02) :224-229